Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Journal of Neuroinflammation
|
August 13, 2010
Effects of mitochondrial dysfunction on the immunological properties of microglia
Annette I Ferger, Loretta Campanelli, Valentina Reimer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 31, 2006
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
Anke Witting, Lanfen Chen, Eiron Cudaback, et al.
Frontiers in Molecular Neuroscience
|
June 13, 2017
Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models
Eva Buck, Hanna Bayer, Katrin S Lindenberg, et al.
Neuropharmacology
|
April 5, 2017
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS
Noemi Pasquarelli, Michael Engelskirchen, Johannes Hanselmann, et al.
Human Molecular Genetics
|
May 17, 2012
A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset
Selma M Soyal, Thomas K Felder, Simon Auer, et al.
Neuron
|
January 3, 2006
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells
Eva Eljaschewitsch, Anke Witting, Christian Mawrin, et al.
Plos One
|
April 14, 2017
High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington's disease expansion mutation carriers shows normal mitochondrial respiratory function
Eva Buck, Martina Zügel, Uwe Schumann, et al.
Scientific Reports
|
August 19, 2017
Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington's disease
Sarah Jesse, Hanna Bayer, Marius C Alupei, et al.
Human Molecular Genetics
|
May 15, 2013
PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis
Judith Eschbach, Birgit Schwalenstöcker, Selma M Soyal, et al.
Neurobiology of Disease
|
November 8, 2016
ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues
Hanna Bayer, Kerstin Lang, Eva Buck, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Journal of Neuroinflammation
|
August 13, 2010
Effects of mitochondrial dysfunction on the immunological properties of microglia
Annette I Ferger, Loretta Campanelli, Valentina Reimer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 31, 2006
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
Anke Witting, Lanfen Chen, Eiron Cudaback, et al.
Frontiers in Molecular Neuroscience
|
June 13, 2017
Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models
Eva Buck, Hanna Bayer, Katrin S Lindenberg, et al.
Neuropharmacology
|
April 5, 2017
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS
Noemi Pasquarelli, Michael Engelskirchen, Johannes Hanselmann, et al.
Human Molecular Genetics
|
May 17, 2012
A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset
Selma M Soyal, Thomas K Felder, Simon Auer, et al.
Neuron
|
January 3, 2006
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells
Eva Eljaschewitsch, Anke Witting, Christian Mawrin, et al.
Plos One
|
April 14, 2017
High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington's disease expansion mutation carriers shows normal mitochondrial respiratory function
Eva Buck, Martina Zügel, Uwe Schumann, et al.
Scientific Reports
|
August 19, 2017
Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington's disease
Sarah Jesse, Hanna Bayer, Marius C Alupei, et al.
Human Molecular Genetics
|
May 15, 2013
PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis
Judith Eschbach, Birgit Schwalenstöcker, Selma M Soyal, et al.
Neurobiology of Disease
|
November 8, 2016
ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues
Hanna Bayer, Kerstin Lang, Eva Buck, et al.
Page
of 3